$KLRS
Kalaris Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$3.20
▲+1.27%+$0.040
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKalaris Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is KLRS up today? It is at $3.20 (+1.27%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KLRS spikes, and full due diligence on KLRS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KLRS 2 times in the last 30 days. Create a free account to track $KLRS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on KLRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KLRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystKalaris Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akkaraju Srinivas Director | Bought (open market) | +244K 1.0% of company | added 12% | 2.22M | $1.2M at $4.83 | May 20, 26 |
Akkaraju Srinivas Director | Sold (automatic/other) | -67K 0.3% of company | sold 0.6% | 10.66M | n/a | May 20, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +19K 0.08% of company | added 0.2% | 12.92M | n/a | May 20, 26 |
Hagen Brett R Officer | Sold (automatic/other) | -2K | n/a | n/a | $13K at $6.72 | Mar 20, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +1.50M 6.3% of company | added 13% | 12.95M | $15.0M at $10.00 | Dec 22, 25 |
Akkaraju Srinivas Director | Bought (open market) | +480K 2.0% of company | added 3.8% | 12.95M | $5.0M at $10.42 | Dec 18, 25 |
Hagen Brett R Officer | Sold (automatic/other) | -907 | sold 32% | 2K | $8K at $8.97 | Mar 26, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on KLRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KLRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
KLRS last traded at $3.20, up 1.27% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Kalaris Therapeutics, Inc. Common Stock (KLRS) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KLRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KLRS 2 times in the last 30 days.
KLRS (Kalaris Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $76M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KLRS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KLRS discussion
Sign in to ask a question or join the discussion.